Integrated Cardio-oncology Service
Lloyd E Butel-Simoes1,2,3,4, Joshua D Bennetts2,3,4, Amanda Croft2,3,4
1Cardiovascular Department, John Hunter Hospital Newcastle, NSW, Australia.
None:
Cancer and cardiovascular disease increasingly intersect in clinical practice. An integrated cardio-oncology service is a coordinated, multidisciplinary programme that embeds cardiovascular risk assessment, on-treatment surveillance and post-treatment follow-up within routine cancer care, supported by shared protocols and decision-making. The aim of such services is to maintain the delivery of best-practice cancer therapy while preventing and treating cardiovascular toxicity. This review distils pragmatic, transferable elements for cardiac and oncology teams: a unified programme with risk-based streaming; nurse-enabled triage and surveillance; pharmacist-led drug-drug interaction stewardship and medication optimisation; fast-track imaging and cardiology access; and clear triggers for escalation that minimise unnecessary cancer therapy interruption. The goal for this review is to provide a pragmatic blueprint for such services, illustrated by international models and our Newcastle bench-to-bedside experience.
More Related Videos
09:40An Ivor Lewis Esophagectomy Designed to Minimize Anastomotic Complications and Optimize Conduit Function
Published on: April 17, 2020
09:37Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition
Published on: August 18, 2022
Related Concept Videos
Integrated Healthcare System
Cardiomyopathy V: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
